- Recent Funding
- Investors
- Fushia Investments
Fushia Investments portfolio
Fushia Investments has 1 portfolio company on record at Recent Funding.
About this page
Its most recent investment on record is Ultromics's $13M Series A round in May 2018, alongside GT Healthcare Capital Partners, Andre Crawford-Brunt, Dieter Spälti and 5 others. That company is in Health and bio.
What Fushia Investments invests in
- Health and bio · 1 · 100%
How Fushia Investments invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series A | 1 100% | $13M |
Fushia Investments portfolio companies
UUltromics$13MSeries A · May 2018
| Company | Round with Fushia Investments | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A · $13M | $111M | Aug 11, 2025 Series B+ |
Most frequent co-investors
OOxford Science Enterprises1 shared round · last May 1, 2018
- GGT Healthcare Capital Partners1 shared round · last May 1, 2018
- AAndre Crawford-Brunt1 shared round · last May 1, 2018
- DDieter Spälti1 shared round · last May 1, 2018
FFuture Planet Capital1 shared round · last May 1, 2018
- RRT Ventures1 shared round · last May 1, 2018
- NNeptune Investment Management1 shared round · last May 1, 2018
- TTanarra Capital1 shared round · last May 1, 2018
Similar investors
AAvant Bio1 company · 1 deal in 12 mo
BBiospring Partners1 company · 1 deal in 12 mo
CColossa Ventures1 company · 1 deal in 12 moCCommerzbank1 company · 1 deal in 12 mo
CCultivian Sandbox Ventures1 company · 1 deal in 12 mo
FFiducia1 company · 1 deal in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Fushia Investments. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Fushia Investments, which is a subset of its real portfolio. API: /api/v1/investors/fushia-investments (get a free API key). More: the most active VC firms and new venture capital funds.